IL6 and COVID-19: The comparison of responses across patients with different COVID-19 severities suggested that pDC response to SARS-CoV-2-infected cells inversely correlates with an exacerbated inflammatory response (as illustrated by IL-6 production by monocytic cells) and a basal level of IFN-I/λ and inflammation activity.